CareLit · DOI-Nachweis · Klinische Pädiatrie
Long Time Survival after Reduced Chemotherapy in a 15-year-old Patient with AML and Candida Krusei Sepsis and Eye Involvement
DOI 10.1055/s-0029-1239536
Bibliografische Angaben
Nachweis in CareLit
Autor:innenB. Bernbeck, G. Janßen, S. Winterhalter, D. T. Schneider, R. Wessalowski
ZeitschriftKlinische Pädiatrie
Ausgabe06/2009
Jahrgang / SeitenJg. 221 · S. 384-385
Kernaussage aus der Literatur
Abstract-Vorschau
Abstract A 15-year-old boy with AML develops a fulminant candida krusei sepsis complicated by acute blindness due to enophthalmitis and subsequent bleeding during prolonged pancytopenia after induction therapy. Despite a low dose prophylaxis with oral nystatine and i. v. amphotericin B (ampho B) three times a week (0.8 mg/kg). Under an early intensified therapy with ampho B (1.5 mg/kg/d) combined with 5-flucytosin (…
Zitieren
Zitierempfehlung
B. Bernbeck, G. Janßen, S. Winterhalter, D. T. Schneider, R. Wessalowski (2009) Long Time Survival after Reduced Chemotherapy in a 15-year-old Patient with AML and Candida Krusei Sepsis and Eye Involvement. Klinische Pädiatrie, 221 (06), 384-385. https://doi.org/10.1055/s-0029-1239536
Mit CareLit weiterarbeiten